Price $232.30 |
Market Cap
3.43B
|
Sector Health Care |
Div. Growth
-
|
P/E
46.5
|
P/B
15.36
|
P/S
4.55
|
Dividend %
-
|
P/CF
215.1
|
P/FCF
48.3
|
Op. Cash Flow
97.2K
|
FCF
4.1
|
Op. Margin
12.60%
|
Net Margin
10.00%
|
ROE
36.20%
|
ROI
32.80%
|
ROA
18.10%
|
EPS Growth
17.70%
|
Current Ratio
1.5
|
Debt/Equity
-
|
Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
---|---|---|---|---|---|
CordovaCann Corp (LVRLF) | $0.09 | - | - | 12.6M | Strong Buy |
InMed Pharmaceuticals Inc (INM) | $0.30 | - | - | 1.6M | Strong Buy |
Navidea Biopharmaceuticals Inc (NAVB) | $0.04 | - | - | 5M | Strong Buy |
Rigel Pharmaceuticals Inc (RIGL) | $1.11 | - | - | 139.2M | Strong Buy |
Nabriva Therapeutics PLC - ADR (NBRVF) | $0.00 | - | - | 1.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More